Direction 1: Classical Imaging + Structured Data Analytics
CerviGuard is the implementation of SmartClover's classical inferential/predictive healthcare AI direction for diagnosis-support workflows.
CerviGuard: AI-centric cervical screening platform for digital-native care teams
CerviGuard is SmartClover's flagship MDR Class I cervical cancer screening companion app for structured intake, AI-assisted analysis, and clinician-led follow-up. It is part of our broader two-direction healthcare AI product strategy spanning the current classical inferential analytics approach as well as our research efforts in the area of generative SaaS systems.
Flagship Healthcare Product
Built for secure, high-trust cervical screening operations
The live pilot at cerviguard.link demonstrates an end-to-end workflow from secure login to AI-assisted case review and follow-up management.
MDR Class I positioning reinforces CerviGuard as a clinical companion, not an autonomous decision maker.Clinical teams stay in command with human-in-the-loop review at every high-impact decision.Role-based access and case traceability support accountable operations in regulated settings.Product delivery supports SaaS and PaaS models without sacrificing data governance control.
How CerviGuard Fits SmartClover's Two AI Directions
CerviGuard anchors the classical analytics direction while SmartClover's generative SaaS products extend prevention communication and qualitative research capabilities.
Direction 2: Generative Healthcare SaaS Systems
SmartClover also focuses on the R&D of generative SaaS systems for primary prophylaxis communication, stakeholder interaction, qualitative questionnaire design, and aggregated-data analysis.
Platform highlights
CerviGuard combines product-grade UX, explainable AI outputs, and deployment flexibility for healthcare teams.
Clinical Workflow Platform
Structured case intake, triage prioritization, and follow-up tracking keep screening operations consistent across distributed teams.
MDR Class I Diagnostic Support
CerviGuard is positioned as an MDR Class I cervical cancer screening companion app with transparent confidence outputs and clinician-led decisions.
Digital-Native Delivery
CerviGuard supports managed SaaS workspaces, private SaaS environments, and PaaS/API-led integrations.
Inside the live application
Screens below were captured from the live pilot on February 17, 2026 using a demo account configured with de-identified training and pilot data.
Workflow from case intake to clinical follow-up
Every stage is structured for operational clarity, transparent signals, and accountable human oversight.
1. Intake
Teams upload de-identified imagery and contextual notes through a secure case-entry workflow.
2. AI processing
CerviGuard computes transformation-zone and lesion-class probabilities, then writes traceable metadata.
3. Clinical review
Clinicians inspect predictions, confidence ranges, and image context before confirming next actions.
4. Follow-up operations
Case status and history remain visible for triage queues, escalation, and longitudinal coordination.
Digital-native SaaS/PaaS deployment model
SmartClover positions CerviGuard as both a product and platform, enabling rapid adoption while preserving governance and integration control.
Managed SaaS Workspace
SmartClover operates the platform as a managed SaaS product with secured pilot onboarding.
Private SaaS Environment
Healthcare organizations can run isolated deployments with residency, policy, and governance controls.
PaaS and API Extensions
Engineering teams can integrate CerviGuard workflows into broader digital health ecosystems through PaaS interfaces.
Products & More
Use this section to review Pricing, How to Buy, Proof, Regulatory, and Trust around CerviGuard.
Need CerviGuard for your screening program?
SmartClover can deliver CerviGuard as a managed SaaS workspace, a private deployment, or a PaaS-integrated product track aligned with your healthcare operations.